Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
10
self-reported band not used
Founded
Not recorded
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
3
Series unknown · Aug 2021
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
AUSTRIANOVA SINGAPORE PTE. LTD.Entity record →
UEN200705334K
Legal entities
Show as table · Austrianova: 1 registry entity
| AUSTRIANOVA SINGAPORE PTE. LTD. | UEN 200705334K |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Austrianova encapsulates living cells in tiny cellulose beads. The beads act as a microenvironment for living cells, allowing them to be metabolically active and divide, whilst being protected from the environment both in vivo (immunoprotection) and in vitro (sheer force, freezing stress protection).
Cell-in-a-Box® enables allogenic or xenogenic mammalian cells to be protected from rejection by the immune system, but their porous nature allows therapeutic bioproducts to be released and encapsulated cells to survive for long periods. Cell-in-a-Box® has many advantages e.g. 1) clinically proven safety and efficacy upon implantation of encapsulated cells in patients 2) cells can grow within the capsules in bioreactors and are thus protected from shear forces - especially useful for fragile cells such as stem cells 3) freezing and storage of encapsulated mammalian cells at -80C for more than 5 years and then revival with greater than 90% viability, thus cells can be easily transported on dry ice.
Bac-in-a-Box® enables probiotic bacteria and yeast to be encapsulated to protect them from harsh environments. Bac-in-a-Box® has a number of advantages e.g. 1) it is based on a natural polymer which is digestible 2) it totally protects probiotics from low pH as found in the stomach for extended periods (hours), allowing almost 100% of ingested probiotic cells to reach and be released in the lower intestine 3) it allows freeze drying of probiotics without appreciable loss of viability so they can be easily stored and transported at room temperature.
We offer cell encapsulation R&D and cGMP production for both
- mammalian cells (stem cells, engineered cell lines etc) all the way from the lab to clinical trial material (Cell-in-a-Box®) and for
- bacteria and yeast encapsulation for excellent long term storage at ambient temperatures as well as 5 to 7 logs better protection from acid degradation in the stomach and later release in the large intestine (Bac-in-a-Box®).
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG3 Biopolis Way; Singapore, Singapore 138623Primary
Grid intelligence Members
Funding
Rounds3
Round typeSeries unknown · venture round
Amount (USD)not recorded
Stage ranknot recorded
Investors named1
Since last round4 yr 5 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2022 to 2026 |
| Series unknown · 7 Aug 2021 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Austrianova?
One Singapore entity on ACRA: AUSTRIANOVA SINGAPORE PTE. LTD. (UEN 200705334K), high confidence.
How many people work at Austrianova?
10 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Austrianova have offices?
One address on record, Singapore only. Primary: 3 Biopolis Way, Singapore 138623.
Has Austrianova raised funding?
Three rounds. Latest 7 August 2021: Series unknown, investor Real Tech Holdings, no amount recorded.
Which companies are listed alongside Austrianova?
7 profiles list Austrianova as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. Celligenics and AITbiotech list it back.